3Nardone G,Holicky EL,Uhl JR,et al.In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection[J].Infect Immun,2001,69(9):5857-5863.
4Wambura C,Aoyama N,Shirasaka D,et al.Effect of Helicobacter pylori-induced cyclooxygenase-2 on gastric epithelial cell kinetics:implication for gastric carcinogenesis[J].Helicobacter,2002,7(2):129-138.
5Romano M,Ricci V,Memoli A,et al.Helicobacter pylori upregulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN28 gastric mucosal cells in vitro[J].J Biol Chem,1998,273(44):28560-28563.
6Ratnasinghe D,Daschner PJ,Anver MR,et al.Cyclooxygenase-2,P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?[J].Anticancer Res,2001,21(3):2141-2147.
7Nabwera HM,Logan RP.Epidemiology of Helicobacter pylori:transmission translocation and extragastric reservoirs[J].J Physiol Pharmacol,1999,50(5):711-722.
8Goldstone AR,Quirke P,Dixon MF.Helicobacter pylori infection and gastric cancer[J].J Pathol,1996,179(2):129-137.
9Glupczynski Y,Megraud F,Lopez-Brea M,et al.European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori[J].Eur J Clin Microbiol Infect Dis,2001,20(11):820-823.
10Gomollon F,Sicilia B,Ducons JA,et al.Third line treatment for Helicobacter pylori:a prospective,culture-guided study in peptic ulcer patients[J].Aliment Pharmacol Ther,2000,14(10):1335-1338.
